LLY
Drug Manufacturers - General · Healthcare
Head of Investor Relations
Head of Investor Relations
ELI LILLY & Co (LLY)Equibles does not estimate personal net worth.
Get an email with a short summary when ELI LILLY & Co publishes a filing, an earnings call transcript or a press release.
Get LLY alertsMike Zappar is recorded as Head of Investor Relations at ELI LILLY & Co (LLY). Mike Zappar has spoken on 3 earnings calls and 1 other investor event across 1 company, most recently for ELI LILLY & Co on October 29, 2026. ELI LILLY & Co is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at ELI LILLY & Co includes Juan Luciano (CEO), David Ricks (Chairman and Board Member), Kimberly Johnson (COO) and 6 others.
“Joining me on today's call are Dave Ricks, Lilly's Chair and CEO, Lucas Montarse, Chief Financial Officer, Dr. Dan Skrivansky, Chief Scientific and Product Officer, During this call, we anticipate making projections and forward-looking statements based on our current expectations.”
“The slides aren't posted on our website, so I know it's kind of like muscle memory when you're at a medical meeting, but they're on there. Lilly Investor Relations.”
“Joining me on today's call are Dave Ricks, Lilly's Chair and CEO, Lucas Montarse, Chief Financial Officer, Dr. Dan Skoromsky, Chief Scientific and Product Officer, Adrian Brown, President of Lili Immunology, Dr. Carol Ho, President of Lili Neuroscience, Ilya Yufa, President of Lili USA and Global Customer…”
“Joining me on today's call are Dave Ricks, Lilly's Chair and CEO, Luis Montarce, Chief Financial Officer, Dr. Dan Skrivonsky, Chief Scientific and Product Officer, Adrian Brown, President of Lilly Immunology, Dr. Carol Ho, President of Lilly Neuroscience, Livia Ufo, President of Lilly USA and Global Customer…”
LLY
Drug Manufacturers - General · Healthcare
Head of Investor Relations